Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series C venture round brings in $15mm for Alveolus

Executive Summary

Alveolus (non-vascular stenting devices for patients with pulmonary or gastrointestinal obstructions) has raised $15mm with its oversubscribed Series C venture round. (The company originally planned to bring in $10mm.) Ridgeback Capital Management led the private financing and was joined by MDS Capital and previous Series A and B backers, including FCA Venture Partners, MB Venture Partners, Healthcare Capital Partners, and Matignon Technologies.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies